Welcome to our dedicated page for Abacus Global Management SEC filings (Ticker: ABL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Abacus Life Inc turns life-insurance policies into alternative assets, so its SEC disclosures dive deep into mortality tables, premium streams, and liquidity schedules that typical investors rarely encounter. If you have ever searched for “Abacus Life insider trading Form 4 transactions” or wanted the “Abacus Life annual report 10-K simplified,” you know how quickly the complexity adds up. Our dedicated page gathers every filing—10-K, 10-Q, 8-K, DEF 14A, and more—in one place, updated the moment they hit EDGAR.
Stock Titan’s AI reads each page so you don’t have to. It extracts cash-flow projections from a “Abacus Life quarterly earnings report 10-Q filing,” flags policy valuation changes in an 8-K, and offers plain-English answers for anyone “understanding Abacus Life SEC documents with AI.” Real-time alerts surface “Abacus Life Form 4 insider transactions real-time,” letting you see executive moves before the market digests them. Need to compare payout ratios across periods? The AI summary sits atop the source PDF, linking straight to the relevant table.
Whether you’re monitoring “Abacus Life proxy statement executive compensation,” reviewing an 8-K for policy portfolio sales (“Abacus Life 8-K material events explained”), or running an “Abacus Life earnings report filing analysis,” our platform turns dense disclosures into actionable insights. Investors use it to track “Abacus Life executive stock transactions Form 4,” study risk disclosures in seconds, and stay ahead of market-moving updates—all without wading through hundreds of pages. Complex documents made clear; decisions made faster.
Abacus Global Management (ABL) announced two capital actions. The Board authorized a stock repurchase program for up to $10 million of common stock, commencing immediately and running through May 6, 2027. Repurchases may occur in the open market or privately negotiated transactions, including accelerated share repurchases, block trades, or pursuant to Rule 10b5-1 trading plans.
The Board also declared an annual cash dividend of $0.20 per share, payable on December 17, 2025 to shareholders of record as of December 2, 2025.
Abacus Global Management (ABL) reported a strong Q3 turnaround. Total revenue reached $62,975,156, up from $28,148,491 a year ago, as Life Solutions contributed $54,122,577 and asset management from related parties added $7,575,553. The company posted net income of $7,075,348 versus a prior-year loss of $5,284,811, with diluted EPS of $0.07 compared to a loss of $0.07. Year to date, revenue rose to $163,339,122 from $78,711,777, and operating income improved to $65,959,737.
Cash and cash equivalents were $86,418,953, and life settlement policies at fair value increased to $423,782,347. The balance sheet reflects higher current debt at fair value of $118,498,871 tied to fund redemption timing, while the warrant liability fell to $0 from $9,345,000. The quarter also included portfolio and platform expansion: the AccuQuote acquisition (non‑cash consideration of $9,265,197), completion of the NIB acquisition, and additional post‑close consideration for Carlisle. Shares issued and outstanding were 97,752,855 as of October 31, 2025.
Abacus Global Management (ABL) furnished an update on its business, announcing results for the quarter ended September 30, 2025 and providing an investor presentation update.
Results were communicated via a press release attached as Exhibit 99.1, and the company plans to post a new investor presentation on its Investor Relations website. The disclosures under Items 2.02 and 7.01 are furnished and not deemed filed under the Exchange Act. The company notes it uses its website to share information that may be material to investors, consistent with Regulation FD.
William H. McCauley Jr., Chief Financial Officer of Abacus Global Management, Inc., reported the vesting and acquisition of 283,333 shares of the issuer's common stock on July 3, 2025 following scheduled and modified restricted stock unit (RSU) awards. The Form 4 shows 0 cash paid for these shares and lists 795,000 shares beneficially owned after the transaction. The filing explains the 283,333-share vesting represents two-thirds of an October 27, 2023 RSU grant (including a March 27, 2025 modification) and details additional time-based RSUs that remain outstanding and will vest in future years, including grants from October 27, 2023; February 13, 2024; December 13, 2024; and April 2, 2025.